NovaBay Pharmaceuticals

$0.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0697 (-8.01%) As of 4:48 PM UTC today

Why Robinhood?

You can buy or sell NBY and other stocks, options, and ETFs commission-free!

About NBY

NovaBay Pharmaceuticals, Inc., also called NovaBay Pharmaceuticals, is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA. The listed name for NBY is NovaBay Pharmaceuticals, Inc.

CEO

Justin M. Hall

Employees

Headquarters

Emeryville, California

Founded

2000

Market Cap

36.13M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

12.44M

High Today

$0.8871

Low Today

$0.7851

Open Price

$0.8801

Volume

828.83K

52 Week High

$1.94

52 Week Low

$0.24

NBY Earnings

-$0.15

-$0.10

-$0.05

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 25, After Hours